Qu Crohn’s Trial Participant Information – Learn what to expect
Dr. Hal Gunn explains what people can expect from Qu Biologics’ Crohn’s disease clinical trial to test Site Specific Immunomodulators (SSIs), a new treatment…
Dr. Hal Gunn explains what people can expect from Qu Biologics’ Crohn’s disease clinical trial to test Site Specific Immunomodulators (SSIs), a new treatment…
SAN MATEO, Calif.–(EON: Enhanced Online News)–EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced today that enrollment for the RESPECT study (Randomized …
JERUSALEM, Israel I September 24, 2013 I BioLineRx (BLRX) (BLRX), a biopharmaceutical development company, announced today that it has filed the necessary regulatory submissions to commence a Phase 1/2 trial for BL-7010 – for the treatment of celiac …